Interventional pain management involves minimally invasive procedures like spinal injections, peripheral nerve blocks and epidural injections to relieve pain. It provides effective solutions by targeting specific nerve pathways and tissues involved in pain signaling and transmission. Common pain management procedures comprise trigger point injections, peripheral nerve blocks and medial branch blocks. These aid in treating chronic pain conditions such as neck and back pain, arthritis, cancer pain and neuropathy. Interventional pain treatments are less invasive alternatives to back surgeries or highly addictive pain medication. They are safe, do not involve extensive recovery time and provide long term relief for pain related to various injuries, illnesses and failed back surgeries.
The Global Interventional Pain Management Market is estimated to be valued at US$ 8.63 Bn in 2024 and is expected to exhibit a CAGR of 3.6% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Interventional Pain Management are AkzoNobel N.V., CABB Group GmbH, Niacet Corporation, and Denak Co. Ltd. These market leaders are focusing on new product launches and geographical expansion to strengthen their market position.
The rising geriatric population worldwide is a major factor driving the demand for interventional pain management procedures. Age related conditions like arthritis and chronic back pain along with the overall reduction in mobility levels fuel the need for such minimally invasive treatments.
Technological advancements are further shaping the interventional pain management space. Developments such as laser ablation, biochemical denervation and advanced spinal cord stimulators are offering better outcomes to patients. Use of robotics, AI and virtual reality aids the precision and accuracy of such procedures.
Market Trends
A key trend in the interventional pain management market is the shift towards ambulatory surgical centers (ASCs). With improved technology and techniques, many minor pain procedures are moving from in-patient to out-patient settings. This is benefitting patients through lower costs and quicker recovery times.
Growing preference for non-opioid therapy is another major trend. Given the risks of addiction with opioid analgesics, interventional methods are garnering increased attention for pain conditions that were traditionally treated with oral narcotics.
Market Opportunities
Rise in neurological disorders worldwide presents an opportunity for interventional pain therapies. Conditions like trigeminal neuralgia, chronic migraines and failed back surgery syndrome are driving procedural volumes.
Higher adoption in emerging nations also offers scope for market expansion. As healthcare infrastructure and services strengthen in these regions, demand for minimally invasive pain solutions will increase at a rapid pace.
Impact of COVID-19 on Interventional Pain Management Market Growth
The COVID-19 pandemic severely impacted the growth of the Interventional Pain Management Market Growth in the initial months. During the peak of the pandemic in 2020, many elective surgeries and non-emergency medical procedures were either postponed or cancelled to avoid the risk of virus transmission and focus medical resources on COVID-19 patients. This led to a steep decline in the demand for interventional pain management devices and therapies. However, with the gradual lifting of lockdowns and containment measures, the market has started recovering from 2021 onwards.
As the fear of virus transmission reduced to some extent with improved treatment options and higher vaccine coverage, people started getting treated for chronic pain issues as well. This helped revive the demand for minimally invasive pain therapies that provide faster recovery and relief compared to oral medications. Moreover, pain clinics and hospitals implemented strict safety protocols like social distancing, use of PPE kits and improved hygiene practices to reassure patients and encourage them to seek pain management procedures. The market is expected to gradually return to its pre-pandemic growth levels by 2024 as ongoing medical research develops more effective and safer interventional techniques.
Regions with Highest Interventional Pain Management Market Value
North America has emerged as the largest and most valuable regional market for interventional pain management globally. The region accounted for over 40% of the total market value in 2024 due to high prevalence of spinal disorders and chronic pain conditions in the US and Canada. Availability of advanced healthcare infrastructure, favorable reimbursement policies, skilled professionals and growing acceptance of minimally invasive therapies have boosted the adoption of interventional pain devices and procedures in this region.
Fastest Growing Region for Interventional Pain Management Market
Asia Pacific region is expected to witness the fastest CAGR of around 5% during the forecast period of 2024 to 2030. Rising geriatric population, increasing income levels, growing awareness about pain management options and expansion of private healthcare sector in developing countries like India and China are some of the major factors fueling the rapid growth of this market in Asia Pacific. Moreover, various initiatives undertaken by governments to enhance healthcare access will continue supporting the demand for cost-effective interventional therapies for pain relief.
Explore more information on this topic, Please visit-
The global fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market in 2018.
The large share of this segment can be attributed to the increasing use of fluoroscopic imaging for diagnosis and interventional procedures and technological advancements in fixed C-arms.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341Surgical applications segment to grow at the highest CAGR in the fluoroscopy equipment market during the forecast period On the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.
The diagnostic applications market is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology), while the surgical applications market covers the market for C-arms in orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications.North America will continue to dominate the fluoroscopy equipment market during the forecast period On the basis of region, the fluoroscopy equipment market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
In 2018, North America accounted for the largest share of the fluoroscopy equipment market.
The large share of North America can be attributed to the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341Leading Companies Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
The global fluoroscopy equipment market is projected to reach USD 7.1 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 4.4%.The major factors driving the growth of the fluoroscopy equipment are the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market, by product, in 2018.On the basis of product, the fluoroscopy equipment market is segmented into fixed C-arms, fluoroscopy systems, and mobile C-arms.
The fixed C-arms segment accounted for the largest share of the fluoroscopy equipment market in 2018.
The large share of this segment can be attributed to the increasing use of fluoroscopic imaging for diagnosis and interventional procedures and technological advancements in fixed C-arms.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341Surgical applications segment to grow at the highest CAGR in the fluoroscopy equipment market during the forecast periodOn the basis of application, the fluoroscopy equipment market is segmented into diagnostic applications and surgical applications.
The diagnostic applications market is further segmented into cardiology, gastroenterology, urology & nephrology, and other diagnostic applications (orthopedics, neurology, and gynecology), while the surgical applications market covers the market for C-arms in orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other surgical applications.North America will continue to dominate the fluoroscopy equipment market during the forecast periodOn the basis of region, the fluoroscopy equipment market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
In 2018, North America accounted for the largest share of the fluoroscopy equipment market.
The large share of North America can be attributed to the increasing incidence of overuse sports injuries, rising prevalence of CVD, and the increasing number of hip and knee replacement surgeries in the region.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=23056341Leading Companies Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
